RxNorm 2569619 NDC Crossover

lonapegsomatropin-tcgd 4.3 MG Cartridge

Related NDC Codes to RxNorm Concept 2569619

The following NDC codes crossover to the RxNorm Concept 2569619. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
73362-003	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-004	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-005	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-006	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-007	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-008	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-009	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-010	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE
73362-011	Skytrofa	Lonapegsomatropin-tcgd	Injection, Powder, Lyophilized, For Solution	Subcutaneous	Ascendis Pharma Endocrinology, Inc.	ACTIVE